web analytics

The Buzz on Pachyderm Labs; Verus International Inc (OTCMKTS: VRUS)

0

Verus International Inc (OTCMKTS: VRUS) continues to make big moves behind the scenes and investors are looking for the next run up in price. The stock was trading over $0.03 just a few months ago and has a significant gap to fill from current levels.

The Company has been busy with its new Pachyderm Labs CBD products. They recently received sufficient inventory at its Houston, Texas facility to support the first phase of distribution and is focused on finalizing  commitments to be in approximately 500 locations by early September, with shipments concentrated in four states – Texas, Florida, Alabama and Georgia.

Verus International Inc (OTCMKTS: VRUS) is a global, emerging multi-line consumer packaged goods (CPG) company developing branded product lines in the U.S., South America, and the Middle East. The Company is an international supplier of consumer products, which it markets under Verus-owned brands to multiple sales outlets. Verus’ initial focus is on frozen foods, particularly meat, poultry, seafood, vegetables, and French fries. Verus has a significant regional presence in the Middle East and North Africa (MENA) and sub-Saharan Africa (excluding Office of Foreign Assets Control (OFAC)-restricted nations), with deep roots in the Gulf Cooperation Council (GCC) countries.

It’s easy to get excited about VRUS if the Company can get a hold of the convertible debt that has decimated the stock in recent months; earlier this year VRUS announced revenue set an all-time record of $6.2 million, an increase of 153% over the $2.4 million reported in Q1 2019. An exciting new division of VRUS is Pachyderm Labs, in the cannabidiol (CBD) space which enters the Verus product family with a fully developed product line, supply chain, distribution channels, inventory, and initial customers. Pachyderm Labs will feature two main brands, “Elephant Hemp” and “U-Try CBD,” and will initially have more than 12 different SKU’s with multiple flavor and aroma variations, covering health-enhancing oils, creams, lotions and other CBD-infused edibles.

To Find out the inside Scoop on VRUS Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

VRUSEarlier this year VRUS announced record revenues reporting results for its first fiscal quarter ended January 31, 2020.  Revenue set an all-time record of $6.2 million, an increase of 153% over the $2.4 million reported in Q1 2019.

Pachyderm Labs has been a stealth initiative under development for nearly a year, so it enters the Verus product family with a fully developed product line, supply chain, distribution channels, inventory, and initial customers. Pachyderm Labs will feature two main brands, “Elephant Hemp” and “U-Try CBD,” and will initially have more than 12 different SKU’s with multiple flavor and aroma variations, covering health-enhancing oils, creams, lotions and other CBD-infused edibles. The brands have been designed for both CBD-oriented retailers and mass retailers such as drug stores and convenience stores.

Pachyderm Labs is making big moves; the Company has already developed 32 SKU’s (stock keeping units) and will initially sell a minimum of 9 different SKU’S per location consisting of topicals and edibles. Pachyderm currently has two brands, “Elephant Hemp” and “U-Try CBD,” representing a full line of products in multiple flavor and aroma variations, covering health-enhancing oils, creams, lotions and CBD-infused edibles. Included in this mix are four newly unveiled CBD-infused energy shot flavors, which are expected to become a featured part of the Pachyderm line.

“This is the first phase of a channel filling period under which we have targeted 10,000 or more stores by early 2021,” explained Verus CEO Anshu Bhatnagar. “We will receive sell-through data after we log a couple of months on retail shelves, but we are pleased with our initial feedback from retailers and customers who have seen and sampled our products. When we have enough locations verified as in-stock, we will publish a list of locations so that analysts and investors can try the products and experience the quality of our brands first hand.”

The Companies Big League Foods division is currently in the planning stage to create packaging and molds for its next professional league introductions. The division’s goal is to have multiple professional sports brands that can overlap seasons, providing BLF a year-round presence on retailers’ shelves. This kind of rotation in seasonal offerings from a single source is highly desirable for retailers, particularly in the impulse aisle at checkout.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading near its all time lows It’s easy to get excited about VRUS if the Company can get a hold of the convertible debt that has decimated the stock in recent months; earlier this year VRUS announced revenue set an all-time record of $6.2 million, an increase of 153% over the $2.4 million reported in Q1 2019. An exciting new division of VRUS is Pachyderm Labs, in the cannabidiol (CBD) space which enters the Verus product family with a fully developed product line, supply chain, distribution channels, inventory, and initial customers. Pachyderm Labs will feature two main brands, “Elephant Hemp” and “U-Try CBD,” and will initially have more than 12 different SKU’s with multiple flavor and aroma variations, covering health-enhancing oils, creams, lotions and other CBD-infused edibles. MicroCapDaily first reported on VRUS in June 2018. We will be updating on VRUS when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with VRUS.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in VRUS either long or short and we have not been compensated for this article.

Share.

Leave A Reply

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.